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Introduction
Autoimmunity is an inappropriate immune response against an
individual's own healthy body tissues. A wide variety of autoimmune
diseases have been identified, and they affect different tissues in different
ways. Some are very specific to particular organs, while others are more
broad ranging in scope.
One example of an autoimmune disorder is myasthenia gravis. This
disease affects the neuromuscular junction. The receptors of the skeletal
muscle cells are blocked and degraded by antibodies. The result is a
gradual weakening of the patient's limbs, as nervous stimulation of the
muscle is inhibited.
Another example of an autoimmune disease is rheumatoid arthritis. The
predominant feature of this condition is inflammation of the synovial joints
throughout the body. Accompanying the inflammation is the destruction of
articular cartilage and the bone beneath it.
This thesis will focus upon rheumatoid arthritis and myasthenia gravis as
examples of autoimmune diseases. It consists of twelve full color
illustrations. Their intended use would be as reproductions in an
undergraduate textbook on immunology. I have chosen to concentrate upon
the cellular and chemical interactions of these pathologies.
In order to properly understand the pathophysiology of an autoimmune
condition, a full discussion of the normal immune response is necessary to
provide background. This discussion begins with a definition of what
provokes an immune response. The immune system is charged with the
task of monitoring all internal regions of the body for foreign substances.
When a foreign substance is detected, it is attacked by an immune response.
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The normal immune system distinguishes a healthy structure that is
supposed to be in the body from a foreign and potentially threatening
substance; in other words, it can distinguish
"self" from "non-self." Any
molecule which is capable of inducing an immune response is termed an
antigen (The New Penguin Dictionary of Biology, 1990).
In order for a molecule to provoke an immune response, a portion of it
must consist of a series of chemical elements which act as a code. The code
is "read" by the immune system and interpreted as foreign. This precise
portion of the antigenic molecule is called either the epitope or antigenic
determinant (Barrett 1988, 38; Tizard 1988, 18) and is the part of the antigen
which will interact directly with the immune system.
The antigenic determinants are structured in accordance with genetic
instructions. The group of genes which defines the distinctive antigenic
determinants of self antigens is called the major histocompatibility complex.
When an immune response is mounted against an invading organism,
such as a bacterium, it is not mounted against the entire organism. Rather, it
is mounted against various antigenic determinants on the molecules which
compose the bacterium. There may be a variety of different antigens upon a
single bacterium, each provoking an immune response (Tizard 1988, 30).
Viruses and pollen grains are two other common sources of antigens.
However, to be identified as a foreign antigen it is not necessary for the
insulting substance to originate from outside the body. Cancer cells
originate from within the body and, if significantly different from normal cells,
will be interpreted as foreign and attacked (Fig. 1).
The germinal event in an immune response is phagocytosis of the
foreign body by cells of the mononuclear phagocytic system (MPS). The
mononuclear phagocytic system is a component part of the immune system,
and is composed entirely of mature macrophages (Roitt 1991, 4).
Macrophages are found throughout the body, but are particularly prevalent
in the lung, liver, lining of spleen sinusoids and lymph node. Macrophages
may be known by another name when found in particular tissues. For
example, a macrophage within the liver is termed a Kuppfer Cell (Roitt 1991 ,
4). Macrophages originate from promonocytes within the bone marrow and
then drift through the circulatory system as monocytes. When they are
mature they migrate into tissues as macrophages (Barrett 1988, 86).
A macrophage may adhere itself to a free surface, such as the lining of a
blood vessel, and wait for an antigen. Alternatively, it may be chemically
attracted to an antigen from some distance away, in which case it will move
against the antigen.
Once an antigen is detected, the macrophage will endeavor to bind the
antigen to keep it from getting away (Barrett 1988, 100). Opsonins are
chemicals in the body which coat antigens to make attachment by
macrophages or other phagocytic cells easier. Some examples of opsonins
are antibodies, fibronectin, and the complement protein C3b. Opsonins
bind to antigens and then lock into receptors upon macrophages. This
linkage makes attachment of the macrophage to the antigen much more
efficient.
There is a tendency for particles or cells suspended in body fluids to take
on a negative charge (Tizard 1988, 43). If both the antigen and phagocytic
cell have negative charges, they will repel each other slightly. Opsonins aid
in attachment by neutralizing any negative charge on the antigen (Tizard
1988,45).
After the attachment is accomplished, the macrophage surrounds the
antigenic substance and seals it within a vacuole. The antigen is moved
towards the macrophage's center while lysosomes provide enzymes to kill it
(Barrett 1988, 101).
Another part of the immune system is what is called humoral immunity.
Humoral immunity involves antibodies circulating in body fluids (Webster's
Medical Desk Dictionary, 1986). An antibody is an immunoglobulin, or a
globulin molecule, produced in response to an antigen (Barrett 1988, 25).
There are five distinct classes of immunoglobulins. The most well-known
and best studied is the IgG class (Barrett 1988, 48). IgG has a molecular
weight of 150,000 daltons, and consists of two pairs of polypeptide chains.
One pair, the heavy pair, is arranged in parallel and bound together by
disulfide bonds. Towards one end, the heavy chains diverge, forming a
"Y"
shape. Adjacent to both divergent upper segments of the
"Y"
shape is a light
chain, one on each side. It is the top two ends of the
"Y"
shape which bind
antigen (Keeton 1986, 775). Antibodies play a central role in the immune
response, so it may not be surprising that antibodies play a central role in
many autoimmune diseases.
Plasma cells are the producers of antibodies. Plasma cells are derived
from B-lymphocytes, as part of the immune response (Fig. 2). B-lymphocytes
are a type of white blood cell. Each B-cell is specifically designed to react
with one specific antigen. No other antigen will have any effect upon a B-
cell except that one particular antigen for which it is specific. Contact with an
antigen is the first step in bringing about the maturation of the B-cell into a
plasma cell (Tizard 1988, 202). B-cells have immunoglobulin molecules
scattered across their surface to act as antigen receptors (Barrett 1988, 116).
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B-cells will sometimes require more than just contact with antigen if they
are to differentiate. A cell which mediates the immune response, known as
the helper T-cell, is sometimes necessary. Helper T-cells must have antigen
presented to it by a cell, such as a macrophage, with MHC class II molecules
in order for it to activate (Sheehan 1990, 31). Once activated, the helper T-
cell produces lymphokines. These lymphokines include B-cell growth factor
(BCGF) and B-cell differentiation factor (BCDF), both of which assist in
promoting the maturation of B-cells to plasma cells (Tizard 1988, 204).
Helper T-cells also secrete a variety of lymphokines which increase the
effectiveness of macrophages (Tizard 1988, 244).
There are some antigens which will provoke B-cell activation and
differentiation without the help of a helper T-cell. These antigens are
classified as T-cell independent antigens (Sheehan 1990, 34).
Myasthenia Gravis
Myasthenia gravis is an autoimmune disease which is chiefly
characterized by increased fatigability of skeletal muscle. Typical symptoms
include slurred speech, nasal voice, drooping eyelids and weakness of the
proximal extremities. The condition is most commonly seen in young adults
(Bullock 1992, 1092). The specific focus of the disease is the acetylcholine
receptors of the neuromuscular junction.
Each individual muscle cell of the body requires direct nervous
innervation. This innervation comes from a branch of a nerve fiber which
does not physically contact the muscle cell. Rather, the terminal end of the
nerve lies within an indentation in the muscle cell, called the neuromuscular
synaptic cleft (Fig. 3). The terminal end of the neuron is almost completely
surrounded by the muscle cell. The terminal end of the neuron and the
small portion of the muscle cell which encircles it is called the motor end
plate. The neuron is separated from actually touching muscle by a small
gap called the synaptic cleft (Ross, Reith and Romrell 1 989, 208). The nerve
may stimulate the muscle to contract by releasing acetylcholine, which
diffuses across the synapse to bind with receptors on the muscle.
The surface of the muscle cell which faces the neuron across the
synapse is not a smooth concave surface. Rather, the surface is broken by
creases arranged parallel to each other. These crevices are termed
subneural clefts. The regions of this undulating surface which form high
plateaus between the subneural clefts are called the junctional folds (Ross,
Reith and Romrell 1989, 210). Located upon these junctional folds are the
acetylcholine receptors (Seybold 1991, 77). The acetylcholine receptors are
protein molecules that are embedded in the bilipid membrane of the muscle
cell. The receptors are 7.8 Angstrom units at their widest points. Their total
height is 11 .5 Angstrom units, with only 4 Angstrom units of it appearing on
the exterior of the muscle cell (Salpeter 1987, 296).
These receptors change shape when acetylcholine binds to them,
allowing a channel to open between the synaptic cleft and the interior of the
muscle cell. This causes a change in the electrical charge of the muscle cell
as sodium ions stream into the cell. If strong enough, a shift in polarity will
be propagated along the muscle fiber and stimulate it to contract (Seybold
1991, 71). When the neuron releases acetylcholine, it usually releases
more acetylcholine than is necessary to depolarize a muscle. However,
acetylcholine is normally broken down very quickly into its two component
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parts: acetic acid and choline. This breakdown is implemented by the
enzyme cholinesterase, a substance normally present in the synapse
(Seybold 1 991 , 71 ). After this transpires, the acetic acid and choline move
back to the neuron to be reabsorbed and reconstituted (Fig. 4).
In the condition known as myasthenia gravis, antibodies produced by the
immune system block and degrade acetylcholine receptors. Exactly what
causes this unfortunate event is at this time unclear. It has been
hypothesized that some unknown antigen may enter the body possessing
antigenic determinants which are very similar to acetylcholine receptors
(Vincent 1990, 182). Thus, the antibodies generated in the ensuing immune
response would cross react with the acetylcholine receptors (Fig. 5). Of all
patients with generalized Myasthenia gravis, 90% test positive for circulating
antibodies specific for acetylcholine receptors (Seybold 1991, 72).
How the antibody blocks the binding of acetylcholine to the receptors
remains undetermined. The receptors are composed of subunits arranged
like staves of a barrel (Seybold 1991 , 71). These have been designated
alpha, beta, gamma and delta. The alpha component is repeated twice,
making for a total of 5 subunits (Salpeter 1987, 296). Acetylcholine binds to
sites located on the two alpha components. Blockage of this binding site
may not be due to the antibody binding to the identical spot where
acetylcholine is supposed to bind. In the majority of cases antibodies bind to
other locations on the receptor, but overlap and block the acetylcholine
binding site. This is called steric hindrance (Drachman et al. 1987, 93).
Alternatively, the antibody may bind directly to the location on the receptor
which binds acetylcholine. Or, it may bind to the receptor in a way which
could prevent the opening of the central ionic channel (Seybold 1991, 72).
Acetylcholine receptors are constantly recycled by the muscle cell. Every
10 to 14 days they are endocytosed and replaced. Antibodies bound to
acetylcholine receptors are capable of fixing blood complement proteins
(Tizard 1 988, 523). The formation of complement into membrane attack
complexes may disrupt the muscle cell's membrane and interfere with
receptor replacement. The degree to which this process contributes to the
disease remains controversial (Seybold 1991, 72).
Anti-acetylcholine receptor antibodies may also degrade the number of
receptors by accelerating their endocytosis. This process relies on the
ability of antibody molecules to bind to more than one antigen at a time.
Receptors may become cross linked by antibodies and drawn together into
tiny clusters on the membrane surface, where they are endocytosed in
groups and enzymatically degraded with enzymes from lysosomes (Fig. 6)
(Drachman et al. 1987, 92; Dixon and Fisher 1983, 277).
One can now comprehend how the transmission of nervous impulses is
impeded from stimulating the muscle fibers during myasthenia gravis.
Acetylcholine is released normally into the synapse. However, the total
numbers of receptors available are reduced. This is due to receptor
blockage from antibodies as well as complement-mediated damage and
accelerated endocytosis of the receptors. Therefore, not enough ions are
released for depolarization of the muscle to occur, and the muscle will not
contract. The result is abnormal muscle weakness and fatigability (Bullock
1992, 1092).
There is no cure for myasthenia gravis, but effective treatments are
available. This usually begins with dosages of anticholinesterase
medications, such as pyridostigmine bromide, ambenonium chloride or
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neostigmine bromide (Seybold 1991, 84). These medications will inhibit the
enzyme cholinesterase from breaking down acetylcholine into acetic acid
and choline. With extra intact acetylcholine in the synapse, it is more likely
that the few receptors remaining will bind to the neurotransmitter. Hence,
depolarization will be sufficient to cause muscle contraction. However, over
dosage of anticholinesterase may cause increased fatigability due to
desensitization of the postsynaptic membrane (Seybold 1991 , 96). Other
therapies include corticosteroids, plasmapheresis and azathioprine
(Seybold 1991 , 86). In 12% of all cases, hyperplasia of the thymus is
evident, sometimes requiring thymectomy. The prognosis for patients with
myasthenia gravis utilizing the current therapies available is generally good,
with the caveat that they may be required to avoid extremely fatiguing
activities (Seybold 1991, 84).
Rheumatoid Arthritis
The most common clinical manifestations of rheumatoid arthritis are pain
and swelling of joints in the extremities. The small joints of the hands and
feet are the most likely to be affected, but involvement of the knees, ankles,
elbows, wrists and hips are not infrequent. Some patients experience
occasional flare-ups and remissions, while others endure a constant attack
of fluctuating intensity (Samter et al. 1988, 1365). Rheumatoid arthritis is
three times more common in women than men. There is a direct correlation
between aging and the frequency of the disease (Samter et al. 1988, 1366).
Studies of twins and familial groups show that genetic factors play a role in
predisposing individuals to developing rheumatoid arthritis (Samter et al.
1988, 1367).
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The synovial joints are a typically involved region of the body in
rheumatoid arthritis. Therefore, it is necessary to briefly define the anatomy
of a healthy synovial joint (Fig. 7). First, the articulating surfaces of the
bones are covered with hyaline cartilage. Hyaline cartilage is composed of
a homogeneous matrix surrounding small dispersed spaces called lacunae.
Within these lacunae live chondrocytes, which are specialized cells
responsible for the production of matrix. The matrix is composed of two
materials, collagen fibrils and ground substance (Ross, Reith and Romrell
1989, 124). The collagen fibrils are formed like archways with the highest
point of the archway adjacent to the free articulating surface and the two
anchor points of the archway down adjacent to the bone (Weiss 1983, 251).
The collagen fiber arrangement can also be compared to a three
dimensional felt-like pattern. The ground substance of hyaline cartilage is
composed of proteoglycans, glycosaminoglycans and glycoproteins (Ross,
Reith and Romrell 1989 123).
Surrounding the joint is a capsule of connective tissue called the joint
capsule. The area enclosed by the capsule is called the joint space and it is
filled with fluid. The joint capsule is vascularized tissue, composed of both
dense and loose connective tissue. The interior lining of the joint capsule is
the synovial membrane, composed of a one to three layer thick surface of
cells termed synoviocytes. These synoviocytes are categorized into three
types. The first type is simply a precursor for the other two, and is called a
type C cell. The second sort of synoviocyte exhibits macrophage-like
phagocytic behavior and is known as the type A cell. The last cell is called
type B. It is responsible for the secretion of the fluid which fills the joint
space (Firestein, Tsai and Zvaifler 1987, 449).
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There are two characteristics which make it easy for substances to pass
into the joint space. First, the capillaries within the joint capsule are highly
fenestrated. Also, the layers of synoviocytes possess no true basement
membrane between them and the adjacent connective tissue (Utsinger,
Zvaifler and Ehrich 1985, 153).
The antigen which initiates the long chain of events known as
rheumatoid arthritis has not yet been identified. It is believed that this
unidentified antigen enters the body and provokes an immune reaction.
However, the antibodies produced in the immune reaction are somehow
altered. Possibly this damage may be due to an enzyme in the inflammatory
process. This alteration of the antibody molecule reveals a new antigenic
determinant. Some genetically predisposed individuals will mount an
immune response against this newly created antigen, generating antibodies
against antibodies, or rheumatoid factor (Fig. 8) (Utsinger, Zvaifler and
Ehrich 1985, 152).
Hence, these antigenic antibodies will become chemically bound to
rheumatoid factor and form immune complexes. These immune complexes
tend to settle within soft connective tissues and hyaline cartilage (Utsinger,
Zvaifler and Ehrich 1985, 151). As immune complexes aggregate, they
activate the complement cascade in what is called a type III hypersensitivity
(Tizard 1988,490).
Current dogma breaks rheumatoid arthritis down into two phases: the
exudative phase and chronic phase. The exudative phase is focused on
polymorphonuclear cells in the joint space and changes in the cells lining
the joint capsule. The chronic phase centers upon interactions between
immune cells within the joint capsule (Ziff 1990, 127).
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Blood complement will increase vascular permeability allowing serum
proteins and cellular blood elements into the region. The first observable
histological change in a synovial joint is perivascular infiltration of
inflammatory cells around the small blood vessels of the capsule, along with
vessel dilation (Samter 1988, 1369). Blood complement will act as a
chemotactic agent for neutrophils, which then move into the synovial joints to
phagocytose the antigen complexes (Fig. 9).
Under ideal conditions, neutrophils first engulf the immune complex
before releasing digestive enzymes (Tizard 1988, 44). Unfortunately, the
location of aggregated immune complexes in rheumatoid arthritis is far from
ideal. The complexes often settle within hyaline cartilage. This is
understandable, considering that between 60 to 78 percent of hyaline
cartilage's net weight is water (Ross, Reith and Romrell 1989, 123). Though
most of this water is bound, some is bound so loosely as to allow materials,
such as immune complexes, to settle within the cartilage matrix. Therefore,
neutrophils are unable to internalize the sequestered immune complexes,
but may still be able to make contact and bind with them. Under these
circumstances, neutrophils release the contents of their lysosomes directly
onto the cartilage. These contents include neutral proteinases and
collagenase which may damage the cartilage by degrading collagen fibrils
and proteoglycans (Fig. 10) (Roitt 1991, 333).
Another complication involving neutrophils is the release of cellular
contents which occurs upon cell death. These contents include kininogens
and vasoactive amines which promote vascular dilation and edema. Other
enzymes promote mast cell degranulation of histamine when released, thus
causing more edema (Utsinger, Zvaifler and Ehrich 1985, 154). Also, type A
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cells of the synovial lining phagocytose immune complexes, releasing
inflammatory mediators in the process. They release enzymes such as
acidic and neutral proteinase which attack proteoglycan (Utsinger, Zvaifler
and Ehrich 1985, 100).
Another observed phenomenon is the enlargement of the lacunae within
the cartilage. It has been theorized that chondrocytes may produce
enzymes which degrade the cartilage matrix. Chondrocytes also tend to
proliferate during rheumatoid arthritis (Utsinger, Zvaifler and Ehrich 1985,
155).
One hallmark of chronic rheumatoid arthritis is pannus formation.
Pannus is the ingrowth of synovial tissue into the joint. It is unclear precisely
what is the stimulus for this, but lymphokines from helper T-cells seem the
most likely candidate. There are three known types of pannus. The first type
appears as immature synovial cells multiplying and advancing across
cartilage from the recesses of the marginal edge of the cartilage. They also
insert themselves between the collagen fibers and proliferate. Thus, the
cartilage is attacked from both outside and from within. Pannus showing
these characteristics is classified as active pannus. There is also a highly
cellular form of pannus which appears as mature granulation tissue,
including fibroblasts, inflammatory cells and blood vessels. A third type is
dense, avascular and acellular, and it is capable of killing cartilage by
blocking its nutrition. It is unclear whether or not these three types of pannus
occur sequentially or independently (Fig. 11) (Utsinger, Zvaifler and Ehrich
1985, 155).
During the chronic phase, blood complement may act as a chemotactic
factor for macrophages, which then move into the synovial joints to
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phagocytose antigen complexes. Macrophages then present the
pathogenic material to lymphocytes, which will in turn interact to produce
more antibodies which add to the aggregation of immune complexes
(Utsinger, Zvaifler and Ehrich 1985, 153).
Besides antigen presentation, macrophages influence lymphocytes
through the release of interleukin-1 . lnterleukin-1 causes T-cells to release
interleukin-2 and B-cell growth factor, which stimulate the growth of B-cells.
lnterleukin-1 also promotes the release of destructive enzymes by dendritic
cells of the synovium (Fig. 12) (Utsinger, Zvaifler and Ehrich 1985, 156).
Not only do macrophages act in an excitatory way on helper T-cells, but
helper T-cells promote macrophage activity through the release of
lymphokines, such as macrophage aggregation factor and macrophage
stimulating factor (Utsinger, Zvaifler and Ehrich 1985, 156).
Some patients with rheumatoid arthritis have been found to have
antibodies to collagen circulating in their blood. This may indicate that an
immune response mounted against damaged cartilage may play a role in
perpetuating the immune response (Samter et al. 1988, 1389). However, it
is believed the primary factor in perpetuation of rheumatoid arthritis is that
macrophages stimulate lymphocytes which then stimulate macrophages and
so the chronic inflammation continues in an endless positive mutual
feedback system (Utsinger, Zvaifler and Ehrich 1985, 157).
It is possible that the cellular interactions involved with the perpetuation
of rheumatoid arthritis may be involved during the routine turnover of
connective tissue during differentiation, growth and repair. But possibly
some vital control mechanism for this natural process may be defective,
causing the perpetuation of the pathology. (Utsinger, Zvaifler and Ehrich
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1985, 157)
Rheumatoid arthritis can not be cured, but treatment plans may be
implemented to reduce pain and swelling while maintaining mobility. Rest is
recommended to reduce stress on afflicted joints. Exercise is useful for
maintaining joint mobility and muscle tone (Porth 1990, 1107). Inflammation
may be reduced by the administration of aspirin and other nonsteroidal anti
inflammatory drugs (Porth 1990, 1108). Rheumatoid arthritis seems to be
modifiable with immunosuppressant drugs, though as of yet only
azathioprine is FDA approved. If inflamed synovial tissue is unresponsive to
drug therapies, then surgical removal of the synovium, or synovectomy, may
be performed. Other surgical treatments include repair of damaged tendons.
In extreme, cases total joint replacements with prosthetics will increase
mobility and reduce pain (Porth 1990, 1109).
Conclusion
Myasthenia gravis and rheumatoid arthritis are both examples of
autoimmune diseases, a category of ailments involving a mistaken attack on
healthy tissues by the immune system. Myasthenia gravis causes harm
through cross reactivity between an antigen and acetylcholine receptors.
Rheumatoid arthritis is in a category of autoimmune diseases known as
immune complex diseases, which cause lesions through the activity of
leukocytes and blood complement. Neither of the antigens which trigger
these conditions has been identified and no cures have been found.
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Technique
At all times I tried to illustrate the various cells as they might look while
alive and inside the body, rather than as they appear in slide preparations.
Scanning electron micrographs proved a valuable source, though some
cells may appear distorted due to artifacts left by processing the specimens.
My choices of color were based on aesthetic judgment, tempered by
consideration of what color a student might be used to seeing the tissue in
his textbooks. For example, I chose light blue as the color for hyaline
cartilage because that is what color it appears in Frank Netter"s medical
illustrations. I chose shades of pink to represent the loose and dense
connective tissue of the joint capsule because that is how it appears when
stained with hematoxylin and eosin.
My technique was fairly consistent throughout the 12 illustrations. I
would first sit down with a pad of drawing paper and a pencil and make a
few rough sketches. Once I had something that I was reasonably happy
with, I would go into the computer lab and begin drawing the outlines of the
objects with Adobe Illustrator. I chose not to utilize the Adobe Streamline
application to trace my sketches because they were drawn roughly. Drawing
with the pen tool in Adobe Illustrator allowed me to further refine my
drawings and experiment with composition.
Once the outline was completed I brought it into Photoshop without anti-
alias. The reason for this was that outlines without anti-alias where much
easier to select with the magic wand tool since they were composed of
adjacent pixels of identical color. The next step was filling in the areas
delineated by the outlines with blends or fills. If a blend and a fill had to be
changed it was much easier to select if the outlines were left black until all
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were complete.
In the illustration entitled What is an antigen?, the forms were simple so
outlining in Adobe Illustrator seemed unnecessary (Fig. 1). For the pollen I
created a tan circle, and then added the shadows and highlights with the
airbrush tool. The crevices in the pollen granules were added with the
pencil tool then smoothed and blended with the finger tool. The viruses
were drawn with a frame work of straight lines, then the highlights were
added with the airbrush.
The cancer cells were B-lymphocytes copied out of the illustration I had
drawn of the immune response. I changed the color of the cell from magenta
to green using the color control menu, then added more texture. The
bacteria were also extracted from the immune response illustration.
The background surface of the illustration depicting the immune
response was created in two steps (Fig. 2). I first drew a small portion of the
texture initially as a separate document. I then utilized the rubber stamp to
clone the texture into the background. I did not want the background to
appear as a wall of identically textured tiles, so I would frequently stop the
cloning process, reselect a different portion of the original texture and start
cloning again.
A large portion of the yellow macrophage's texture was drawn with the
drawing tools, then cloned using the same start and stop method used for
the background. I added the core shadow with the airbrush tool.
The lymphocytes were constructed by making a radial blur in a selected
circular area, then adding reflected light with the airbrush tool and a dab of
white with the paintbrush tool adjusted to 50% opacity to intensify the
highlight. The texture was drawn with the pencil tool. The plasma cell had
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to be drawn with the paint brush and airbrush tool since the radial blend only
works in a perfect circle. The nucleus was a radial blend drawn on a
separate document and pasted into the cell at 50% opacity. The rough
endoplasmic reticulum was drawn by hand with the pencil tool. All
antibodies throughout the thesis are the same antibody duplicated, resized
and rotated. The bacteria were filled with solid red color, then shadows,
highlights and details were added with the drawing tools.
The anatomy illustration of the synovial joint was relatively straight
forward (Fig. 7). Everything was drawn as a flat color or blend, except for the
texture of the bone which was drawn as a small portion, then duplicated to
fill the space.
The neutrophils appearing in the illustrations were not drawn with fills or
imported outlines (Figs. 9 and 10). Instead, I delineated the edges of the
form with the pen tool and converted it to a selection. Then with the airbrush
tool, I selectively added purple shadows and white highlights while leaving a
portion of the background behind the cell still visible. The nuclei and the
arterioles were rendered with the various drawing and painting tools.
In the illustration representing a neutrophil eating through collagen, the
fibers were drawn with lines of various shades of blue, each one pixel wide
(Fig. 10). Some fibers were then rotated to appear broken.
The panoramic landscape view of the cartilage undergoing destruction
began as a relatively refined pencil drawing, which was then scanned on a
flat bed scanner and opened in photoshop (Fig. 11). First the image was
recomposed by moving and distorting various areas. This was purely for
aesthetic reasons. Then a blend from blue to red was added to the
background from left to right. Then the surface plane was filled with a blend,
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allowing it to lighten as it neared the horizon line. I wanted to maintain the
pencil texture in the canyon and pannus. So, I selected the largest diameter
for the paintbrush tool but set it to color only, and then proceeded to
"colorize"
those areas.
The explosion from the bursting neutrophil in the foreground was too
opaque in the pencil drawing. To make the material appear transparent I
utilized the rubber stamp set to 30% opacity to clone areas of the pannus
into the explosion area.
Out of all the illustrations of my thesis work, the pair portraying the
neuromuscular junction are my favorites (Figs. 4 and 6). The majority of
these illustrations, including the muscle and the yellow neuron, were painted
with airbrush onto Color-Aid paper and then scanned into Photoshop 2.0.
The shapes of the receptors in the foreground were then masked off with the
pen tool and rendered. The receptors in the middle ground and background
were all the same receptor which was repeatedly duplicated, resized and
rotated. The ions streaming out of the receptors were stippled in with the
pencil tool.
The acetylcholine molecules started out as green and yellow spheres in
a separate document. The component parts were then pasted in, each time
lightly altering their juxtaposition. Straight lines connecting the two portions
of the molecules completed them.
The orientation drawing for these two illustrations began with the basic
cylindrical forms for the muscle cells (Fig. 3). I first attempted making a blend
to show the basic form. The difficulty lay in how the linear blend worked.
You must make a straight line perpendicular to the length of the cylinder.
When the cylinder is at an oblique angle the perpendicular is difficult to
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discern. It would have been easier to discern the perpendicular angle if I
had drawn the cylinder as a horizontal, then rotated the whole image later.
But this did not occur to me at the time.
The nerve fiber was outlined with the pen tool, then filled with yellow. A
shadow was added with the airbrush tool. The inset was a selection pasted
in from the neuromuscular junction illustrations. The dark rings, or A bands,
of the muscle cell began as one circle drawn in brown. Then, the upper right
portion of it was selected, duplicated and placed in a pattern, working from
front to back, gradually adjusting the opacity setting to reduce contrast as
distance increased.
The illustration demonstrating cross reactivity was initiated with linear
blends in all of the objects, then shadow and highlights were intensified with
the airbrush tool (Fig. 5). Since the antibody molecules were so large, I
opted not to utilize the antibody file I had been using earlier. Instead, I drew
a new one using various shades of gray line one pixel wide, each drawn
adjacent to the next. Straight neutral gray objects in an otherwise full color
image tend to stand out as artificial, so I set the airbrush tool to color only,
selected the pink hue of the muscle, and added it to the antibody as reflected
light.
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Figure 1
An antigen is any substance which is capable of evoking an
immune response.
Figure 2
Depicted above are the cellular interactions of an immune response. A
macrophage (yellow) engulfs some bacteria, then activates a B-cell (pur
ple) and a T-cell (red). The helper T-cell releases chemical mediators
which cause the B-cell to differentiate into the much larger plasma cell,
which produces antibodies specific for that bacteria.
Figure 3
This is an orientation illustration designed to show the location of the
neuromuscular junction. A nerve fiber branches out to innervate a number
of muscle cells. The inset is a magnified view of a single neuromuscular
junction.
Figure 4
The terminal end of the nerve lies within an indentation in the muscle cell,
called the neuromuscular synaptic cleft. The nerve may stimulate the
muscle to contract by releasing acetylcholine, which moves across the
synapse to bind with specialized receptors on the muscle's surface. The
receptor then changes shape, allowing ions to stream in and out.
Figure 5
Myasthenia gravis is believed to be caused by a process called cross
reactivity. Antibodies are produced against an antigen that, by co
incidence, is very similar in chemical structure to the acetylcholine re
ceptors of muscle cells. These antibodies bind to the receptors, thereby
incapacitating them.
Figure 6
Antibodies bind to acetylcholine receptors during myasthenia gravis. Not
only does this block the receptors from binding to acetylcholine, but also it
promotes their endocytosis by the muscle cell.
Figure 7
The synovial joints are the most typically involved region of the body in
rheumatoid arthritis. This cut away view shows the major structures of the
synovial joint. The region within the small black rectangle is magnified in
figures 9 and 12.
Figure 8
Antibodies are protein molecules which bind with an antigen as part of the
immune response. Normally, the binding sites of the antibody attach to an
antigen as a step towards the antigen's destruction. In rheumatoid ar
thritis, an antibody binds to an unknown antigen that is capable of trans
forming the structure of the antibody. A region of the antibody is revealed
which the immune system interprets as a foreign antigen. The immune
system then synthesizes rheumatoid factors, which are antibodies that
bind to the altered antibodies. When antibodies and antigens are bound
together, they are called immune complexes.
Figure 9
The immune complexes of rheumatoid arthritis tend to settle within ar
ticular cartilage. Phagocytic cells from the blood, called neutrophils, move
towards the articular cartilage after chemically sensing these aggregated
complexes.
Figure 10
Neutrophils normally attempt to engulf immune complexes before they
release their digestive enzymes. However, if the immune complexes are
sequestered within the cartilage matrix, neutrophils release enzymes di
rectly onto the cartilage. These enzymes damage the collagen fibrils com
posing the cartilage.
Figure 11
This is a microscopic panoramic view of the articular cartilage undergoing
destruction from rheumatoid arthritis. Neutrophils move across the cor
roded surface in search of sequestered immune complexes. The neu
trophils continue to ingest material until they burst open. The background
at left shows a formation of pannus, an ingrowth of the synovial membrane
which can damage cartilage and fuse joints.
Figure 12
This illustration shows some of the chemical interactions between cells
within the joint capsule. Macrophages activate helper T-cells through anti
gen presentation. The helper T-cells attract more macrophages by re
leasing lymphokines. Lymphokines induce macrophages to release IL-1 ,
which in turn causes the dendritic cells to release enzymes that are de
structive to cartilage. The T-cells and macrophages work in concert to pro
mote the B-cells to differentiate into plasma cells. The plasma cells pro
duce antibodies which add to the formation of new immune complexes,
perpetuating the inflammatory response.
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